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Abstract
Rhoptry protein belongs to an excretory and secretory antigens (ESAs) that play an important role during active
penetration of parasite into the cell target. This  protein an able Toxoplasma gondii to actively penetrate targeted
cell, meanwhile ESAs protein stimulates intracellular vacuole modification. It is, therefore, after the parasite
successfully enter the cell target then Granule (GRA) proteins are responsible for the formation of parasitophorus
vacuole, which is protect the fusion  with other intracellular compartments such as lysosomal vacuole. Consequently,
this parasite is being able to survive and multiply at the cell target. The current study was aimed to clone and
sequens cDNA encoding for ROP-2 of local isolated T. gondii tachizoite through DNA recombinant technique.
Total ribonucleic acid (RNA) was isolated from tachyzoites of local isolated T. gondii that were grown up in Balb/
c mice. Messenger RNA was isolated from total RNA using PolyAtract mRNA Isolation System. Messenger RNA was
used as a template for synthesis cDNA using Riboclone cDNA Synthesis System AMV-RT. EcoRI adaptor from
Riboclone EcoRI Adaptor Ligation System was added to Complementary DNA and than ligated to pUC19. Recombinant
plasmid was transformed into E. coli (XL1-Blue). The transformed E. coli XL-1 Blue were plated on LB agar
containing X-Gal, IPTG and ampicillin. Recombinant clones (white colony) were picked up and grown up in the
LB medium at 37oC overnight. Expression of recombinant protein was analysed by immunoblotting in order to
identify cDNA recombinant wich is  express  ESA of  T.  gondii local isolate. Recombinant plasmid were isolated
using alkalilysis method and were elektroforated in 1% agarose gel. The isolated DNA recombinant plasmid was
cut using Eco RI and then sequenced through Big Dye Terminator Mix AB1 377A Sequencer using M13 Forward and
M13 Reverse primers. The conclusion of this results showed that the recombinant clone was coding for excretory
and secretory protein which has molecular weight of 54 kDa. The DNA alignments of sequence from the cloned
gene showed 97% homology with gene encoding for ROP-2 of T. gondii RH isolate.
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Backgrounds
Toxoplasma gondii is an intracellular
parasite, infect all warm blooded animals
including human. This parasite is belonging
to an opportunistic pathogen and considered
as a master of mind of toxoplasmosis (Dutta
et al., 2000). Toxoplasmosis is one of an
extensively diseases spread worldwide in
mammals. However the disease prevalence
is vary based on geographic and climate
condition. In general, an infected mammal
with good immune system does not develop
any symptoms. When the immune system is
adversely weakened, the symptoms are
likely to be manifested such as encephalitis
and ocular lesion (Yamamoto et al., 2000;
Martin et al., 2000).  The most excellent  step
to decrease prevention risk hit toxoplasmosis
compared to medication (Wisnuwardhani,
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1990). Mohammed et al. (1994) suggest that
in order to decrease the risk of toxoplasmosis
at foetus is by vaccination before pregnancy.
The vaccine of diluted tachyzoites T.
gondii (live attenuated) was reported can
prevent abortus in an animal and the sheep
have been already used commercially
(Alexander et al., 1996). The constraint of
toxoplasmosis vaccines by using intact
parasite among others is  treatment of
tachyzoites which  is not peaceful expensive
and also felt concerned about to become
virulen strain, especially in human which is
having trouble at their immune system. The
progress of a toxoplasma vaccines for human
being shall pursuant in the direction of usage
of recombinant antigens or a synthetic
peptide which perfectly  given protection for
hospes from all life cycle phase T. gondii
(Prigione et al., 2000).
  Toxoplasma gondii is a Protozoan
parasite, living obligate in the any type of
nucleated cell (Sibley et al., 1995). Tachyzoite
has secretory bodies. The main immunogenic
proteins of such secretory bodies are surface
antigen (SAG), granulocyte antigen (GRA)
and rhoptry antigen (ROP) (Pfrepper et al.,
2000; Nischick et al., 2000; Guanjin et al., 2001;
Reichmann et al., 2000; Martin et al., 2000).
Those three proteins act as a facilitator of host
cell infection, invasion and parasitophorus
development (Ajioka, 2001).
 The antigen especially SAG and ESA
has a direct relationship with
immunopathogenesis and cell invasion.
Surface antigens is related with attachment
process into membrane of infected cell.
While ESA plays an important role in active
penetration process and modification of
parasitophorus vacuole in the cell targeted.
Each of antigens is consisted of several
antigen proteins in which respective protein
has different functions.
Cesbron-Delauw et al. (1996) found a
given ESA antigen with Incomplete Freud
Adjuvant (IFA) was able to protect mice from
oral infection in lethal dose of T. gondii cyst
(survival rate was 50-60%). Fischer et al.
(1998) and Jacobs et al. (1999) conducted a
29 kDa dense granule antigen (GRA7) related
study, while Vercammen et al.  (2000)
investigated a 23kDa dense granule antigen
(GRA1), GRA7, 54kDa rhoptry antigen
(ROP2) as well. ESA protein has a higher
complexity compared to SAG based on
protein variation as pathogenesis factor.
Penetration of Toxoplasma into targeted
cells give a response of releasing a certain
ESA protein. In addition, ESA protein
causes parasitophorus vacuole to be unable
to fuse with other intracellular
compartment such as lisosomal vacuole
(intracellular vacuole modification).
Consequently, T. gondii tachyzoites are able
to survive and freely multiply in the infected
cell.
The effective and efficient vaccines at the
moment are required, therefore DNA
recombinant technology is expected can
solve internal issue of ESAs which are
immunogenic enough for that purposes.
DNA recombinant can also given a standing
by solution  of DNA vaccine or  probe for
toxoplasmosis.
The current study is aimed to clone and
to identify cDNA encoding ESA of local
isolated T. gondii tachyzoites through DNA
recombinant technique.
Materials and Methods
Excretory- secretory antigens (ESA)
isolation from tachyzoit of Toxoplasma
gondii
Excretory-secretory antigens were
obtained from local isolated T. gondii, by
cultured the tachyzoites (109 tachyzoites /
ml) in RPMI 1640 medium supplemented
by 10% FCS. The suspension of tachyzoites
was incubated in 37oC for 3 h by
continuously agitation. Following the
incubation, the suspension of tachyzoites
was centrifuge on 3500 rpm, 4oC, for 10
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min and the obtained supernatant was ESA
protein. ESA protein was identified by SDS-
PAGE and stained using 0.2 % coomasie
brilliant blue R-250.
Production of polyclonal antibody against
ESA protein
The ESA protein was used as an antigen
to induce polyclonal antibody production.
Five female mice (BALB/c strain), age 8-10
weeks, each was immunized by
intraperitoneal routes using 5 μg of ESAs
protein in the solution containing of
phosphate buffered saline and IFA
(incomplete freund adjuvant) in equally
volume (1:1) Immunization was repeated 5
times with two weeks interval. The obtained
serum (polyclonal antibody against ESA
protein) was used for screening of
recombinant ESA protein.
Total RNA  Isolation
Total RNA isolated from tachyzoites T.
gondii local isolate using Total RNA isolation
kit (Promega) as described by manufacturer.
Messenger RNA was isolated from total RNA
using PolyAtract mRNA Isolation System
(Promega).  The procedures consist of
annealing probe, washing SA-PMPs, capture
of annealing oligo (dT)-mRNA hybrids and
mRNA elution.
The cDNA synthesis
Messenger RNA was used as a template
for cDNA synthesis using Riboclone cDNA
Synthesis System AMV-RT (Promega). EcoRI
adaptor from Riboclone®EcoR I adaptor
Ligation System was linked to the
phosphorylated cDNA and the adaptors
excess was removed using Sephacryl S-400.
Ligation of cDNA into expression vector.
One microliter pUC19 (200 ng/µl) was
added with 2 µl cDNA kinase, 1µl ATP, 1 µl
10 X buffer T4 DNA ligase and nuclease free
water until final volume 10 µl,  then
incubated at 16oC, for overnight.
Dephosphorilated pUC19 was ligated to
previously modified cDNA.
Bacterial transformation
Before transformation, Escherichia coli
XL-1 Blue competent were prepared by fresh
exponential phase bacterial culture (OD 600
e” 0,5) in LB medium containing 10% PEG
6.000 (w/v), 5% DMSO (v/v) and 35 mM
MgCl2. Different concentration of
transformed bacteria were spread on LB agar
plate containing ampicillin, X-Gal and IPTG
then incubated at 37oC for overnight. White
bacteria colonies were picked up and grown
in 5 ml LB medium containing ampicillin for
overnight. The growing bacteria were
centrifuge at 4,000 rpm, 10 min, 4oC and the
pellet was extracted for further plasmid
preparation.
Analysis of recombinant plasmid
Recombinant clones were picked up,
grown in the LB medium and incubated at
37oC for overnight. Plasmid was isolated
using alkalilysis methods, digest with EcoRI
and electrophoresis at 1% agarose gel.
Recombinant protein was isolated and
electrophoresis at 10% SDS-PAGE and
transfer onto nitrocellulose membrane.
Nitrocellulose membrane was stained with
amidoblack for protein detection and for
immunoblotting, nitrocellulose membrane
was incubated with polyclonal antibody
against ESA protein.
cDNA Sequencing
The recombinant plasmid was
sequenced at Molecular Biology of Eijkman
Institute, Jakarta using Big Dye Terminator
Mix ABI 377A sequencer. DNA alignment
analysis was performed using NCBI Blast
and Clustal W.
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Results and Discussion
The ESA protein profile
Excretory-secretory antigens is defined
as total protein that secreted and excreted
from tachyzoites T. gondi. Those proteins
are composed of the mixture of all dense
granule, rhoptry and micronema proteins
(Cesbron-Delauw, 2001). The ESA’s profile
were shown in several protein as known at
13 kDa, 14 kDa, 17 kDa, 37 kDa, 44 kDa,
54 kDa, 71 kDa, 81 kDa, 98 kDa, 113 kDa
and 131 kDa (Cesbron-Delauw, 2001).
In order to define ESA’s expressed from
recombinant bacteria was analyzed based
on molecular weight in the 12% SDS-PAGE
as shown in Figure 1.
Figure 1.  Profile of ESAs protein tachyzoites
Toxoplasma gondii M: protein marker; lane 1 and 2.
ESA protein
RNA of Toxoplasma gondii
The total RNA of Toxoplasma gondii was
run on 1% agarose gel was shown in Figure
2. Messenger RNA (mRNA) was isolated
from 4.392 μg/μl total RNA using
PolyATract mRNA Isolation System. In this
regard the yield of mRNA was sufficient for
twice synthesis of cDNA.
Figure 2.  Electrophoresis of Total RNA Toxoplasma
gondii local isolate M. Marker RNA ribosom, lane 1.
Total RNA
Figure 3. Electrophoresis of plasmid  on  1 % agarose
gel M. Marker, lane 1.  undigested pUC19,  lane 2.
pUC19 digested with Eco R1, lane 3. Recombinant
Plasmid, lane 4. Recombinant Plasmid digested with
Eco R1
Recombinant protein identification
The profile of recombinant protein in
line 1 was compared with the control (E.
coli XL-1 blue) and blue colony showed
different profile of ribbons.
The profile of recombinant protein in
the 1st line, if it is compared with the marker,
showed presumably a 54kDa protein
expression. The molecular weight of ribbon
of recombinant protein in line 3 was 54kDa,
calculated by regression equation
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Recombinant plasmid analysis
Plasmid from recombinant clones were
isolated using alkalilysis method and
electrophoresis on 1% agarose gel. The result
was shown in Figure 3.
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(attachment 8). Recombinant of Excretory -
Secretory Antigens (ESA) with molecular
weight 54kDa was identified as ROP 2
protein.
Recombinant colony lisate protein in
line 1 showed different pattern of ribbons
with those from blue colony and E.coli Xl-1
Blue. The obtained protein was identified
by electrophoresis in 12% polyacrilamide
gel. The result is showed in Figure 5.
Figure 5.  Profile lisat recombinant protein in 12%
polyacrilamid gel M. Protein Marker, Lane 1.
Recombinant  Protein, Lane 2.  E.coli  XL-1 Blue Protein
And Lane 3.  Blue Colony.
Figure 6. The Immnublotting of recombinant Protein
from SDS-PAGE 12% with antibody polyclonal to ESA.
M. Marker, Lane 1.  Lisate  protein E. coli XL1-Blue, 2.
lisate recombinant protein, Lane 3. lisate recombinant
protein, Lane 4. Lisate protein E. coli XL1-Blue
(without pUC19), Lane 5. lisate protein blue colony
(pUC19 whithout  insert)
The result of immunoblotting of several
recombinant  protein with antibody
polyclonal towards ESA protein is showed
in Figure 6. The importance result of the
recombinant protein is able to applied for
vaccine candidate or strong inducer of
immune response (Vercammen et al., 2000).
DNA sequencing
Sequencing was done by the use of
pUC/M13 forward sequencing primer and
pUC/M13 reverse sequencing primer in the
available pUC19 vector construct (Promega).
Sequencing with pUC/M13 forward had
resulted a 719 bp.
The sequence was analyzed with
BLAST program to identify the cloned gene.
Sequence that showed a significant
alignment was ROP2 protein-encoding gene
of T. gondii RH isolate. Recombinant DNA
sequence alignment  was showed 97%
homology with ROP2 gene of the 49th base
to the 561st base RH isolate (Figure 7).
Sequencing of plasmid recombinant
was done with pUC/M13 forward
sequencing primer and  pUC/M13 reverse
sequencing primer (available at pUC 19
vector construct/Promega). The analysis of
the DNA sequence obtained from the
BLAST program revealed a significant
degree with gene encoding rop2 T. gondii
RH isolate. Sequence alignment sequenced
using pUC/M13 forward showed 99%
homolog from base 49 until 561. Alignment
sequence which sequenced using pUC/M13
reverse showed 95% the differences were
lied on base 967 and 1628. The difference
bases at 1330 did not change the amino acid;
(GTT to GTC: Valine ), difference at 1500
did not change the amino acid; (TGC to
TGT: Cysteine), and difference at 1592 lead
to alter amino acid glutamic acid (GAA) to
alanic acid (GCA). Transformation of
glutamic acid into alanic acid, in the
chemical structure, is not significantly
different. It is, therefore, no change on
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Query  124 GCCAATTTGTGGTATGTGGCAACCGTCTGCATTGAATCCGCCGTAGTCAACACGAGATGC  183
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  49 GCCAATTTGTGGTATGTGGCAACCGTCTGCATTGAATCCGCCGTAGTCAACACGAGATGC  108
CDS ROP2 p               M  L  A  T  V  C  I  E  S  A  V  V  N  T  R  C
Query  184 AGCTGCTCACGCTGGAAATCATTGATTCTTCCCGCTTTGTGGGAGGCACGCGTATGTAGG  243
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  109  AGCTGCTCACGCTGGAAATCATTGATTCTTCCCGCTTTGTGGGAGGCACGCGTATGTAGG  168
CDS ROP2 p S  C  S  S  R  W  K  S  L  I  L  P  A  L  W  E  A  R V C  R
Query  244 GTAAAGACATCTAGCAAAGCAACTCCACGAGTATCGGTGGCCCCA-CGCAAGTGACGGAG  302
          ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||
Sbjct  169 GTAAAGACATCTAGCAAAGCAACTCCACGAGTATCGGTGGCCCCAGCGCAAGTGACGGAG  228
CDS ROP2 p V  K  T  S  S  K  A  T  P  R  V  S  V  A  P  A  Q  V  T  E
Query  303 CGCCTACAGAGACGAACATCCGACCCACGCACCGACTGTCCTTCCATCGTAGTTGACGTT  362
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  229 CGCCTACAGAGACGAACATCCGACCCACGCACCGACTGTCCTTCCATCGTAGTTGACGTT  288
CDS ROP2 R  L  Q  R  R  T  S  D  P  R  T  D  C  P  S  I  V  V  D  V
Query  363 TTGAGCCATGCTGCAAAACTGCACGCAGTAGTGAGGAGAATGGTATCCACGTCATCTTGT  422
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  289 TTGAGCCATGCTGCAAAACTGCACGCAGTAGTGAGGAGAATGGTATCCACGTCATCTTGT  348
CDS ROP2 p L  S  H  A  A  K  L  H  A  V  V  R  R  M  V  S  T  S  S  C
Query  423 TTTTCCGCGTGTATTTCAGAAGATTCTCGCGAGAACTGTGGATGCCCTTGTCACATGGTA  482
          |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  349  TTTTCCGCGTGTATTTCAGAAGATTCTCGCGAGAACTGTGGATGCCCTTGTCACATGGTA  408
CDS ROP2 p F  S  A  C  I  S  E  D  S  R  G  N  C  G  C  P  C  H  N  V
Query  483 ACGGTTGTTTTGTGTGTTACACATCTGCAACATGGAAAACTG-GCGTCGGTCAGATCATC  541
          |||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
Sbjct  409 ACGGTTGTTTTGTGTGTTACACATCTGCAACATGGAAAACTGTGCGTCGGTCAGATCATC  468
CDS ROP2 T  V  V  L  C  V  T  H  L  Q  H  G  K  L  A  A  S  V  R  S
Query  542 GTCGTGTCTTATCTGGCTAGCTGCCGCATTCTTTGTTTCGGCACTTGGCCACGTACAGCA  601
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  469 GTCGTGTCTTATCTGGCTAGCTGCCGCATTCTTTGTTTCGGCACTTGGCCACGTACAGCA  528
CDS ROP2 V  V  S  Y  L  A  S  C  R  I  L  C  F  G  T  W  P  R  T  A
Query  602  AGGCGCTGGCGTTGTGCGGCCTCGCCACTGGCA  634
|||||||||||||||||||||||||||||||||
Sbjct 529   AGGCGCTGGCGTTGTGCGGCCTCGCCACTGGCA  561
CDS ROP2 p R  R  W  R  C  A  A  S  P  L  A
Figure 7. Alignment DNA recombinant (The result of sequence with M13 forward primer) and gene encoding  ROP2
RH isolate.
protein structure as well as no influence on
epitope of ESA protein.
Conclusion
Complementary DNA from T. gondii
local isolate was successfully cloned into
pUC19 vector and transformed to XL-1 Blue
E.coli. The correspondence sequence of
cDNA was encoding of a 54-kDa protein.
Alignment analysis of the sequenced cDNA
was shown 97% homology with the rop2
gene of T. gondii RH strain.
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Query  59 CGGTACGGATCCTGGAGACGTCGTCATATGGGAGTTNTTCAATCGTATACCGGAAAACAA  119
|||||||||||||||||||||||||||||||||| |||||||||||||||||||||||
Sbjct 1628 CGGTACGGATCCTGGAGACGTCGTCATATGGGAGCTGTTCAATCGTATACCGGAAA-CAA  1568
CDS ROP2 p                              M  G  ↓  X  Q  S  Y  T  G  K  Q
                                             1592
Query  120 GCGTATGGAATGAGAACGAACGCGNCCTGTCGAACGCCAACCATCTTCTAGTGTCCACAG  180
|||||||||||||||||||||||| |||||||||||||||||||||   |||||||||||
Sbjct  1567 GCGTATGGAATGAGAACGAACGCGTCCTGTCGAACGCCAACCATCT—AGTGTCCACAG  1507
CDS ROP2 p A  Y  G  M  R  T  N  A  X  C  R  T  P  T  I  F     C  P  Q
Query  181 CATTGTTGGCGTAATGAGCAGAGCTTCCGCGTGGAGTCGGAGCTGGGCGAGCGTCCAAGG  241
||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct 1506  CATTGCTGGCGTAATGAGCAGAGCTTCCGCGTGGAGTCGGAGCTGGGCGAGCGTCCAAGG  1446
CDS ROP2 p H  ↓  W  R  N  E  Q  S  F  R  V  E  S  E  L  G  E  R  P  R
               1500
Query  242 ACGCTAGTCAGAGGCCCAGTGCTCCGCGACGACGGCTCGTATATCTGTCTCGAGGCGACC  302
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct 1445  ACGCTAGTCAGAGGCCCAGTGCTCCGCGACGACGGCTCGTATATCTGTCTCGAGGCGACC  1358
CDS ROP2 p T  L  V  R  G  P  V  L  R  D  D  G  S  Y  I  C  L  E  A  T
Query  303 GACCAGGAGACAGGAGCAATCCCACTTGAGGTGCACGTTCCATATTTCACGGAACGGCCG  363
|||||||||||||||| |   |||||||||||||||||||||||||||||||||||||||
Sbjct  1357 GACCAGGAGACAGGAGAA—CCACTTGAGGTGCACGTTCCATATTTCACGGAACGGCCG  1297
CDS ROP2 p D  Q  E  T  G  ↓     P  L  E  V  H  V  P  Y  F  T  E  R  P
                           1330
Query  364 CCTTCCCAACGCGATCAAGCAGTTGAGCGAGCAGGTGCTGCGCCTACGCTTGCTACGAGG  424
|||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  1296 CCTT-CCAACGCGATCAAGCAGTTGAGCGAGCAGGTGCTGCGCCTACGCTTGCTACGAGG  1236
CDS ROP2 p P  S  Q  R  D  Q  A  V  E  R  A  G  A  A  P  T  L  A  T  R
Query  425 CATCAAAAACCAGAGGCAAGCCAAAGGGGCGTATCTCAGATTTATATTCCCCATCGATTT  485
||||||||||||||||||||||||   |||||||||||||||||||||||||||||||||
Sbjct  1235 CATCAAAAACCAGAGGCAAGCCAA—GGCGTATCTCAGATTTATATTCCCCATCGATTT  1175
CDS ROP2 p H  Q  K  P  E  A  S  Q  R  G  V  S  Q  I  Y  I  P  H  R  F
Query  486 GGTGAAGGACCCAAAG——GGAAGATGATCCGGGTTCGCTTAGATGAGAGGGATATGTG  546
||||||||||||||||    ||||||||||||||||||||||||||||||||||||||||
Sbjct  1176 GGTGAAGGACCCAAAGAAAAGGAAGATGATCCGGGTTCGCTTAGATGAGAGGGATATGTG  1116
CDS ROP2 p G  E  G  P  K       G  K  M  I  R  V  R  L  D  E  R  D  M
Query  547 GGTCTTGAGCAGATTCTTTCTGTATCCCCGAATGCAGAGTACCCTTCATATTCTTGGAGA  607
         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  1115 GGTCTTGAGCAGATTCTTTCTGTATCCCCGAATGCAGAGTACCCTTCATATTCTTGGAGA  1055
CDS ROP2 p G  L  E  Q  I  L  S  V  S  P  N  A  E  T  P  S  Y  S  W  R
Query  608 CGTCCCCCTACTGAGTCATTCCTCNNNNNNNNCAAGTCCCTCGTGCACCACGCTCGGTTG  668
|||   ||||||||||||||||||  || | |||||||||||||||||||||||||||||
Sbjct  1054 CGT—CCTACTGAGTCATTCCTC—AACACACAAGTCCCTCGTGCACCACGCTCGGTTG  994
CDS ROP2 p R  P  P  T  E  S  F  L  X  X  X  K  S  L  V  H  H  A  R  L
Query  669 CAGCTCACGCTTCAGCTCATAAGGTTGG  695
||||||||||||||||||||||||||||
Sbjct  993  CAGCTCACGCTTCAGCTCATAAGGTTGG  967
CDS ROP2 p Q   L  T  L  Q  L  I  R  L
Figure 8. Alignment DNA recombinant (The result of sekuensing with pUC/M13 reverse primer)
and gene encoding  ROP2 RH isolate.
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